AzTrials
AzTrials

Out-Of-Hospital Cardiac ArrestWOHCANCT05132387

Wroclaw Out-Of-Hospital Cardiac Arrest Registry

An observational study of Out-Of-Hospital Cardiac Arrest, run by Wroclaw Medical University at 1 site in Poland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to assess the efficacy of institutionalized care program of patients with out-of-hospital cardiac arrest. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Out-Of-Hospital Cardiac Arrest
What is being tested?
ECMO assisted CPR in out-of-hospital cardiac arrest
How many people
50 participants
Where
1 sitePoland
Study dates
25 Oct 2021to 1 Jan 2028
How long will I take part?
1 Month
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Study population: Patients with out-of-hospital cardiac arrest which occured in the predefined area of the city of Wroclaw, Poland.

Who may be able to join

  • Age < 60 years
  • witnessed sudden cardiac arrest with immediate CPR
  • supposed cardiac cause of the event
  • ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) at first medical contact with 3 unsuccessful defibrillations (no ROSC)
  • CPR conducted with Lund University Cardiopulmonary Assist System (LUCAS™)
  • Estimated transfer time from the scene to the Emergency Department < 30 minutes.
  • End tidal carbon dioxide (ETCO2) > 10 mmHg

Who cannot join

  • Total presumed time from 112 call to ECMO implantation longer than 60 minutes
  • Age < 18 years old or > 60 years old;
  • Non-shockable initial rhythm
  • Unavailability of the automated CPR device
  • Unavailability of the catheterisation laboratory
  • Severe concomitant illness with decreased life expectancy
Show all 10Show fewer
  • Severe body injury
  • Severe active bleeding
  • Drowning
  • Terminal cancer

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Wiktor Kuliczkowski, MD contact

+ 48 603 707 093

wiktor.kuliczkowski@umw.edu.pl

Poland1 site, 1 recruiting
  • Wroclaw University Hostpital

    Wroclaw, 50-556

    Wiktor Kuliczkowski, MD, + 48 603707093, wiktor.kuliczkowski@umw.edu.pl

    Recruiting

Other trials in Poland

About this study

The purpose of this study is to assess the efficacy of institutionalized care program of patients with out-of-hospital cardiac arrest.

Read the detailed description

Patients with out-of-hospital cardiac arrest included in the program will be treated with extracorporeal membrane oxygenation (ECMO) assisted cardiopulmonary resuscitation (CPR) with additional invasive procedures including coronary/pulmonary angiography and intervention. This type of treatment was not provided in institutionalized fashion in Wroclaw, Poland. Implementation of this program should improve survival in out-of-hospital cardiac arrest patients, which currently is less than 10%.

Being tested
ECMO assisted CPR in out-of-hospital cardiac arrest
Keywords
Cardiac arrest, ECMO, ECMO-CPR
Medical subject headings
Out-of-Hospital Cardiac Arrest, Heart Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ECMO assisted CPR in out-of-hospital cardiac arrestOther

    Patients included in the registry will be transferred during LUCAS assisted CPR by the Wroclaw Emergency Medical Services to the Emergency Department of the Wroclaw University Hospital where blood gasses will be assessed. If two or more of the following: end-tidal carbon dioxide (CO2) > 10 mm Hg, arterial partial pressure of oxygen (PaO2) >50 mm Hg or oxygen saturation >85%, and lactic acid <18 mmol/L will be fulfilled patient will be further transferred to the Cardiac Catheterization Laboratory for V-A ECMO implantation followed by coronary/pulmonary artery angiography and intervention.

Study groups in NCT05132387
Study groupRoleWhat they receive
Out-of-hospital cardiac arrestPatients with out-of-hospital cardiac arrest which occured in the predefined area of the city of Wroclaw.
Receives: Other: ECMO assisted CPR in out-of-hospital cardiac arrest

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. mortality

    all cause mortality

    Measured: 1 month

Secondary outcomes (1)
  1. degree of disability

    Modified Rankin Scale of 3 or lower

    Measured: 3 and 6 months after index event

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2021
  2. Study start25 Oct 2021
  3. Primary completion31 Oct 2027 (estimated)
  4. Study completion1 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (estimated)
Target duration
1 Month
IDs, dates and publications
ClinicalTrials.gov ID
NCT05132387
Sponsor's protocol ID
327/2021
Acronym
WOHCA
Status last verified
Mar 2025
First submitted
12 Nov 2021
Last updated
30 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Sip M, Puslecki M, Klosiewicz T, Zalewski R, Dabrowski M, Ligowski M, Goszczynska E, Paprocki C, Grygier M, Lesiak M, Jemielity M, Perek B. A concept for the development of a pioneer regional Out-of-Hospital Cardiac Arrest Program to improve patient outcomes. Kardiol Pol. 2020 Sep 25;78(9):875-881. doi: 10.33963/KP.15433. Epub 2020 Jun 16.

    PubMed 32550730
  • Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray TA, Collins G, Zhang L, Kalra R, Kosmopoulos M, John R, Shaffer A, Frascone RJ, Wesley K, Conterato M, Biros M, Tolar J, Aufderheide TP. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020 Dec 5;396(10265):1807-1816. doi: 10.1016/S0140-6736(20)32338-2. Epub 2020 Nov 13.

    PubMed 33197396

Questions about this trial

What is this clinical trial studying?

An observational study of Out-Of-Hospital Cardiac Arrest, run by Wroclaw Medical University at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 30 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Wiktor Kuliczkowski, MD (+ 48 603 707 093, wiktor.kuliczkowski@umw.edu.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

mortality (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05132387, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in